Pages

Tuesday, March 29, 2011

Respiratory Diseases- Asthma

Asthma is a common disease in the general population, with an overall prevalence in the US in 2002 of 7% reported by the National Center for Health Statistics. It is caused by a complex interaction of inflammatory cells, mediators, and cytokines, which can induce bronchoconstriction and, as a result, airflow obstruction.

This is a cardinal feature of asthma at any age. There is a common misperception that asthma is predominantly a childhood disease. However, in a survey of elderly persons from four communities in the US, the prevalence of physician-diagnosed asthma was 4%, with another 4% having probable asthma (symptoms of asthma without a diagnosis). This is similar to other estimates that 7–9% of individuals over the age of 70 have asthma. New-onset asthma is most common in childhood, but it may occur at any age, even in the eighth and ninth decades of life. It is often under-recognized or misdiagnosed in the elderly. A proper evaluation of asthma symptoms can lead to early diagnosis, proper treatment, and avoidance of unnecessary emergency department visits and hospitalizations.
http://www.mededsys.com/product_info.php?cPath=2_29&products_id=258&osCsid=qj5fvv3p44tugl278np3oja497

The Diagnosis of Asthma in the Elderly
Unfortunately, the diagnosis of asthma is frequently overlooked in the geriatric population. Some elderly patients are reluctant to admit their symptoms, or consider them a result of normal aging. Under-reporting of symptoms in the elderly may have many causes, including depression, cognitive impairment, social isolation, denial, and blaming of symptoms on other comorbid illnesses. Even when symptoms are reported, lung function testing to confirm the diagnosis is often not carried out. On the other hand, the diagnosis of asthma is frequently confused with chronic obstructive pulmonary disease (COPD), a disease usually, but not always, associated with cigarette smoking. http://www.mededsys.com/product_info.php?cPath=2_29&products_id=258&osCsid=qj5fvv3p44tugl278np3oja497

Thursday, March 24, 2011

Pulmonary Function Testing

Pulmonary function testing has come into widespread use since the 1970s. This has been facilitated by several developments. Because of miniaturization and advances in computer technology, microprocessor devices have become portable and automated with fewer moving parts. Testing equipment, patient maneuvers, and testing techniques have become widely standardized throughout the world through the efforts of professional societies. Widely accepted normative parameters have been established.
Pulmonary function testing is a valuable tool for evaluating the respiratory system, representing an important adjunct to the patient history, various lung imaging studies, and invasive testing such as bronchoscopy and open-lung biopsy. Insight into underlying pathophysiology can often be gained by comparing the measured values for pulmonary function tests obtained on a patient at any particular point with normative values derived from population studies. The percentage of predicted normal is used to grade the severity of the abnormality. Practicing clinicians must become familiar with pulmonary function testing because it is often used in clinical medicine for evaluating respiratory symptoms such as dyspnea and cough, for stratifying preoperative risk, and for diagnosing common diseases such as asthma and chronic obstructive pulmonary disease.
Pulmonary function tests (PFTs) is a generic term used to indicate a battery of studies or maneuvers that may be performed using standardized equipment to measure lung function. PFTs can include simple screening spirometry, formal lung volume measurement, diffusing capacity for carbon monoxide, and arterial blood gases. es. Widely accepted normative parameters have been established. http://www.mededsys.com/product_info.php?cPath=2_29&products_id=261

Wednesday, March 23, 2011

Respiraroty Diseases and Neuromuscular Disorders

Neuromuscular Disorders Affecting Respiratory Muscles

-Poliomyelitis
-Guillaine-Barre Syndrome
-Myasthemia Gravis
-Muscular Dystrophy

The mechanisms which respiration is affected by during neuromuscular diseases are variables that include reduced muscular force for adequate ventilation, disturbance of certain reflexes important for protection of the lung from aspiration of food, gastric content, and upper airway secretions.  Mechanisms are also affected by impairment of effective cough for clearing of air passages, diminished or absent periodic, voluntary or involuntary, deep-breathing maneuvers, lack of mobility with its inherent problems, and dysfunction of the respiratory center. Frequently, more than one of these mechanisms is involved.

Diseases of the Muscles

The major primary muscular diseases that may involve respiratory function are muscular dystrophies and inflammatory myopathies.

            Muscular Dystrophies
Muscular dystrophies are a group of hereditary conditions characterized by a progressive degeneration
of the striated muscles, resulting in increasingly severe weakness. They have been classified accordingto certain clinical and genetic features. The most common form is Duchenne dystrophy,
which is inherited as X-linked, recessive trait, and therefore, is essentially a disease of males. Other forms, which have autosomal type of inheritance, are seen in both sexes.

The onset of muscular weakness, which is the only presenting symptom in most cases, is quite variable. In Duchenne dystrophy, the weakness starts early in life in the proximal muscles of the extremities. Once the child starts to walk, certain abnormalities can be detected, which become more evident as he grows older. Movements such as getting up from a sitting position or climbing stairs, which require proximal muscular strength, become more and more difficult. In early adolescence, the victim is usually unable to walk. In other forms of muscular dystrophy, the onset is later, and they are usually designated according to the group of muscles that are primarily involved.
In myotonic muscular dystrophy, in addition to progressive muscular weakness, there are certain distinctive features. Difficulty of relaxing the contracted muscles such as a hand grip, known as myotonia, is quite characteristic. Early development of cataract, testicular atrophy, and frontal baldness are other associated features. Pulmonary complications are much more common in myotonic dystrophy than in other forms. In addition to the difficulties related to respiratory muscle involvement, there are frequent problems with swallowing and aspiration. Pulmonary function studies in most cases of muscular dystrophy demonstrate some abnormalities. Reduced vital capacity, maximum voluntary ventilation, and maximum expiratory and inspiratory forces are quite common. The severity of these abnormalities depends on the degree of respiratory muscle involvement. Pulmonary infection is a common cause of death in these unfortunate individuals. Respiratory insufficiency is frequently aggravated by an intercurrent infection, which may result in fatal respiratory failure. In overall management of these patients, the importance of proper respiratory care cannot be overemphasized. http://www.mededsys.com/product_info.php?cPath=2_29&products_id=147





 

Monday, March 21, 2011

Respiratory Therapist and Nurses

Continuing Education

Medical Education Systems, Inc. http://www.mededsys.com/ is one of the most cost effective CE solutions online school, and is backed by a strong history of innovation, customer service and easy-to-earn distance learning courses(ceus-ce). Our goal is to provide healthcare professionals with the highest quality continuing education credits for nurses and respiratory therapists at the most effective prices and to offer the best service available in the industry.

Asthma

CAUSES OF ASTHMA

Some people think there is only one cause of asthma symptoms. But actually, asthma symptoms have two main causes, and both occur within the airways of your lungs:


AIRWAY CONSTRICTION

This is the cause of asthma symptoms that you may feel as a tightening in your chest. The muscles around the airways of your lungs squeeze together or tighten. This tightening is often called "bronchoconstriction," and it can make it hard for you to breathe. http://mededsys.com/

INFLAMMATION

This is the cause of asthma symptoms you probably do not notice. If you have asthma, the airways of your lungs are always inflamed, and they become more swollen and irritated when your asthma symptoms worsen. Inflammation can reduce the amount of air that you can take in or breathe out. In some cases, too much thick mucus is produced, which further obstructs the airways.
Together, airway constriction and inflammation narrow your airways, which can result in wheezing, coughing, chest tightness, or shortness of breath—likely familiar feelings to you. And in people with asthma, the airways may be inflamed even when they are not having symptoms. http://mededsys.com/

Thursday, March 17, 2011

COPD

Global Initiative for Chronic Obstructive Lung Disease (GOLD)
The condition known as COPD has been associated with considerable confusion and disagreement among health care professionals. Even defining the term has been somewhat controversial—much less determining how to diagnose and manage the condition. Given the relative confusion and disagreement among health care professionals regarding the topic of “COPD,” it was an historic breakthrough that on April 4, 2001, the medical world was greeted with the following important news release:

FOR IMMEDIATE RELEASE
Wednesday, April 4, 2001
Contact:   NHLBI Communications Office
                (301) 496-4236

International Guidelines Released on Chronic Obstructive Lung Disease (COPD)
Fourth Leading Cause of Death in US and Worldwide

The first international guidelines for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease (COPD) — currently the fourth leading cause of death in the US and worldwide — were released today by an international team of scientists from the Global Initiative for Chronic Obstructive Lung Disease (GOLD). The GOLD Workshop Report, which provides evidence-based recommendations for the clinical management of COPD, is the first step in an international effort to boost awareness of COPD and improve the way it is treated. GOLD was created by the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health and the World Health Organization.
According to NHLBI Director Dr. Claude Lenfant, "COPD has become a major public health problem worldwide. That's why we, with the WHO, initiated this program. We hope that this report will increase worldwide awareness of COPD and help the millions of people who suffer from this disease."
COPD, a term used to describe chronic bronchitis and emphysema, is a slowly progressive airways disease characterized by a gradual loss of lung function. In the US, it is caused primarily by cigarette smoking. There is no known cure, but smoking cessation can slow disease progression.
COPD has been on the increase in the US, and in 1996, an estimated 16 million Americans had COPD. The number of deaths attributed to COPD has also increased substantially in the past 40 years to approximately 100,000 men and women per year in the US alone. The highest rate of increase in deaths has been seen in white women.
It is expected that by 2020, COPD will rank as the third leading cause of death, surpassing stroke. The annual cost of COPD to the US economy is estimated at nearly $30.4 billion.
The GOLD Report, which was reviewed extensively by medical societies in more than 100 countries throughout both the developed and developing world, emphasizes the need for clinicians and patients to recognize cough and sputum production as early signs of possible COPD and calls for the use of spirometry, a simple test of lung function, to confirm the diagnosis. It also provides a general scheme for classifying COPD by severity to help clinicians determine how best to manage the condition. http://www.mededsys.com/product_info.php?products_id=153

Wednesday, March 16, 2011

Continuing Education

Medical Education Systems, Inc. http://www.mededsys.com/ is one of the most cost effective CE solutions online school, and is backed by a strong history of innovation, customer service and easy-to-earn distance learning courses(ceus-ce). Our goal is to provide healthcare professionals with the highest quality continuing education credits for nurses and respiratory therapists at the most effective prices and to offer the best service available in the industry. 

Wednesday, March 9, 2011

Diabetes CEUS

Researchers have revealed that around 50,000 people are told they have diabetes when they do not have the condition. The American Diabetes Association (ADA) has been actively involved in the development and dissemination of diabetes care standards, guidelines, and related documents for many years. These statements are published in one or more of the Association’s professional journals. This supplement contains ADA’s "Standards of Medical Care in Diabetes," our major position statement, which contains all or key recommendations. In addition, contained herein are selected position statements on certain topics not adequately covered in the "Standards." We hope that this is a convenient and important resource for all health care professionals who care for people with diabetes. http://www.mededsys.com/ offers a great Diabetes courses for nurses.

Friday, March 4, 2011

Ceus Renewal

Medical Education Systems, Inc. provides home study courses and contact hours (CEU's) for EMTs, Nurses, Respiratory Therapists, Sleep Therapists, and other healthcare professionals. MedEdSys is one of the most cost effective CEU solutions online, and is backed by a strong history of innovation, customer service and easy-to-earn distance learning courses. Today MedEdSys almost 100 classes for a variety of healthcare professionals. Take advantage of our special and get a free 3-4 unit course with a purchase of a 10+ course.http://www.mededsys.com/

Thursday, March 3, 2011

Ceus-Continuing Education-CRCEs

Medical Education Systems, Inc., one of the earliest online Respiratory Therapy CEU providers to offer a robust selection of online and print classes, today MedEdSys offers almost 100 classes for a variety of healthcare professionals. http://www.mededsys.com/  free 3 unit ceus with purchase of 10+ unit course. Nursin Ceus? Repiratory Care Ceus? We have a huge variety of courses and topics. Take advantage now, do not wait until the last minute to fullfilled your requirements.

Wednesday, March 2, 2011

Illinois Respiratory Therapist-Ceus Due October 2011

Every renewal applicant shall complete 24 hours of continuing education. MedEdSys's 
goal is to provide healthcare professionals with the highest quality continuing education at the most cost effective prices and to offer the best service available in the industry. Medical Education Systems, Inc. provides home study courses and contact hours (CEU's) for EMTs, Nurses, Respiratory Therapists, Sleep Therapists, and other healthcare professionals.
We understand that every profession has different requirements for contact hours as set forth by your professional society and your state board requirements. Visit http://www.mededsys.com/%20and  take advantage of our large selection of courses and our great prices! 

Tuesday, March 1, 2011

Whopping Cough Booster Shot Requirement

Whopping Coug(pertussis) has been widespread in California during 2010. In addition, a new California law will require that in the year 2011-2012 school year all the students entering 7th-12th grade be inmunized against pertussis, including having received Tdap pertussis booster shot. Our new courses is available for Nurses and Repiratory Therapist. Here are some of the Learning Objectives:Identify the recent rise in interest in whooping cough, Identify the clinical features and etiology of whooping cough, Identify who is at risk for being infected by whooping cough, Identify the available treatments for whooping cough today, Identify the key features of the history of whooping cough. Check out our site to find out more http://www.mededsys.com/